glp-1 agonists for diabetes Clinical Focus on in Type 2 Mellitus GLP-1 Agonists In Obesity
Description
5.2 Safety evaluation In both clinical trials and real-world settings, tirzepatide has demonstrated a favorable safety and tolerability profile
Endocr Connect 10(7):R200R212
The first indication was provided by a small, pilot study in patients with diabetes
If you are curious about what those first weeks feel like, the initial experience on semaglutide varies considerably from person to person, though most people notice appetite suppression within the first one to two weeks
These advanced therapeutics hold the potential to revolutionize the management of metabolic disorders by providing sustained benefits for glucose control, weight loss, and overall metabolic health [80,81,82] (Table 1)
Effect of Liraglutide on Body Weight and Microvascular Function in Non-diabetic Overweight Women with Coronary Microvascular Dysfunction
